Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet. (Q51475312)

5 April 2018

title

Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet. (English)

1 reference

5 April 2018

1 reference

Michelle Lee

1

1 reference

5 April 2018

Andrea Kim

2

1 reference

5 April 2018

Streamson C Chua

3

1 reference

5 April 2018

Silvana Obici

4

1 reference

5 April 2018

Sharon L Wardlaw

5

1 reference

5 April 2018

publication date

20 March 2007

1 reference

5 April 2018

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

5 April 2018

volume

293

1 reference

5 April 2018

page(s)

E121-31

1 reference

5 April 2018

issue

1

1 reference

5 April 2018

Brain melanocortin receptors: from cloning to function

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Impaired coordination of nutrient intake and substrate oxidation in melanocortin-4 receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

The melanocortin system and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Proopiomelanocortin-deficient mice are hypersensitive to the adverse metabolic effects of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Proopiomelanocortin and energy balance: insights from human and murine genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Anatomy and regulation of the central melanocortin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Melanocortin-independent effects of leptin on hepatic glucose fluxes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Chronic application of MTII in a rat model of obesity results in sustained weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Peripherally administered [Nle4,D-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Altered levels of POMC, AgRP and MC4-R mRNA expression in the hypothalamus and other parts of the limbic system of mice prone or resistant to chronic high-energy diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Targeted disruption of the melanocortin-4 receptor results in obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Food conversion is transiently affected during 4-week chronic administration of melanocortin agonist and antagonist in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Effects of agouti-related protein on metabolism and hypothalamic neuropeptide gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

CNS melanocortin and leptin effects on stearoyl-CoA desaturase-1 and resistin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Interactions between the melanocortin system and the hypothalamo-pituitary-thyroid axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

The physiological function of the agouti-related peptide gene: the control of weight and metabolic rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Central melanocortin receptors regulate insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

A brain-liver circuit regulates glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Metabolic effects of transgenic melanocyte-stimulating hormone overexpression in lean and obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Central nervous system control of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Melanocortin-4 receptor mRNA is expressed in sympathetic nervous system outflow neurons to white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Central administration of alpha-melanocyte-stimulating hormone inhibits corticotropin-releasing factor release in adrenalectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1 beta and alpha MSH: studies in rats with different susceptibility to inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

Heterozygosity for aPOMC-Null Mutation and Increased Obesity Risk in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00555.2006

10.1152/AJPENDO.00555.2006

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

PubMed ID

17374695

1 reference

5 April 2018